Similar articles

• Paediatric steatotic liver disease has unique characteristics: A multisociety statement endorsing the new nomenclature.

  European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN); European Association for the Study of the Liver (EASL); North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN); Latin‐American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (LASPGHAN); Asian Pan‐Pacific Society for Pediatric Gastroenterology, Hepatology and Nutrition (APPSPGHAN); Pan Arab Society for Pediatric Gastroenterology and Nutrition (PASPGHAN); Commonwealth Association of Paediatric Gastroenterology & Nutrition (CAPGAN); Federation of International Societies of Pediatric Hepatology, Gastroenterology and Nutrition (FISPGHAN). European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), et al. J Pediatr Gastroenterol Nutr. 2024 May;78(5):1190-1196. doi: 10.1002/jpn3.12156. Epub 2024 Mar 26. J Pediatr Gastroenterol Nutr. 2024. PMID: 38529849
• Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: A joint position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso).

  Moreira RO, Valerio CM, Villela-Nogueira CA, Cercato C, Gerchman F, Lottenberg AMP, Godoy-Matos AF, Oliveira RA, Brandão Mello CE, Álvares-da-Silva MR, Leite NC, Cotrim HP, Parisi ER, Silva GF, Miranda PAC, Halpern B, Pinto Oliveira C. Moreira RO, et al. Arch Endocrinol Metab. 2023 Nov 27;67(6):e230123. doi: 10.20945/2359-4292-2023-0123. Arch Endocrinol Metab. 2023. PMID: 38048417 Review.
• Beyond a liver-gut focus: the evolution of gastroenterology and hepatology in challenging the obesity and steatotic liver disease paradigm.

  Brennan PN, Zelber-Sagi S, Allen AM, Dillon JF, Lazarus JV. Brennan PN, et al. Gut. 2024 Mar 7;73(4):560-563. doi: 10.1136/gutjnl-2023-330771. Gut. 2024. PMID: 37898546 Free PMC article. No abstract available.
• From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD): an ongoing journey towards refining the terminology for this prevalent metabolic condition and unmet clinical need.

  Kokkorakis M, Boutari C, Katsiki N, Mantzoros CS. Kokkorakis M, et al. Metabolism. 2023 Oct;147:155664. doi: 10.1016/j.metabol.2023.155664. Epub 2023 Jul 28. Metabolism. 2023. PMID: 37517792 No abstract available.
• [Effect of the nomenclature of non-alcoholic fatty liver disease on diagnosis and treatment of fatty liver disease concomitant with other liver diseases].

  Chen L, Jiang LN, Zhao JM. Chen L, et al. Zhonghua Gan Zang Bing Za Zhi. 2023 Aug 20;31(8):805-809. doi: 10.3760/cma.j.cn501113-20230810-0050. Zhonghua Gan Zang Bing Za Zhi. 2023. PMID: 37723061 Review. Chinese.